Clinical Conductor CTMS Release Targets Precise, Accurate Research Management

July 14, 2015 – ROCHESTER, NY – The latest iteration of Clinical Conductor CTMS continues the proven strategy of providing research organizations with the most in-depth features and functionality available, further distancing the application from others in the industry, which fail to provide the tools necessary for truly complete clinical research management. 

The new Clinical Conductor contains a myriad of enhancements that foster more precise reporting and analysis, resulting in greater confidence in the accuracy of study and patient information, yielding greater confidence in decision making and overall business management. Updates can be seen throughout the application, with standout enhancements made to billing compliance review processes, intuitive invoicing advancements, adverse event management and reporting, forecasting, and overall system workflow efficiency. All enhancements to Clinical Conductor are aimed at meeting current and future industry needs while facilitating compliance, efficiency and profitability in conducted clinical research.

The billing compliance review enhancements in Clinical Conductor CTMS give organizations the tools they need to confidently identify charges that will be allocated to sponsors, Medicare, third-party payers and other financial entities, in a manner that is compliant with federal and state regulations. This enhanced section of Clinical Conductor gives sites in-depth billing display pages that clearly highlight important information such as procedure details, CPT codes, completion locations and more. With this comes a granular audit trail of what and when an item was reviewed, as well as who was the reviewer. Sites can also restrict access to this functionality to specific users on their team. This billing compliance review functionality also flows nicely to Clinical Conductor Enterprise users, who can review and give final approval on all items up for billing review.

The CTMS invoicing also received detailed updates that give research organizations more flexibility and greater accuracy while reviewing and generating invoices. Now, organizations can implement varying invoice frequencies within a single budget, while adhering to predetermined invoicing caps. From there, invoices and reports can be generated in real time, with all relevant invoicing data directed to the forecasting reports within Clinical Conductor CTMS for the most accurate cash and revenue projection possible.

Knowing how critical patient safety is to the industry, Clinical Conductor CTMS has received additions to the adverse event (AE/SAE) management functionality included in the system. Now, Clinical Conductor is fitted with an AE reporting wizard for more accurate and thorough reporting of AEs and SAEs. To build on this, users can now add customized notes for additional AE information, in addition to having the ability to upload any other necessary documents that pertain to an adverse event. Monitors and Sponsors can also access the real-time AE/SAE reports via Clinical Conductor portals to ensure compliance and patient safety is consistent with the study protocol.

“Underestimating the importance of precise data gathering and accurate reporting can be costly for organizations regardless of how many studies they run,” states Bio-Optronics VP and COO Jeff Markin. “The team behind Clinical Conductor provides the industry the only CTMS aimed atyielding more reliable data analysis and better decision making, with greater research profitability overall. By embracing this philosophy, we provide an invaluable tool research organizations come to rely on for years and through countless clinical trials.” 

.